Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic Cancer

Name: Open-Label, Phase 1 Clinical Trial of Neoadjuvant Nogapendekin Alfa Inbakicept, Sotevtamab, and Zabadinostat in Combination With Gemcitabine and Nab-Paclitaxel for Participants With Borderline Resectable or Locally Advanced Pancreatic Cancer
License: Public Domain

ImmunityBio, Inc.

ClinicalTrials.gov · Datasets · License: Public Domain

Open Source ↗

pancreatic-cancer

pancreatic cancer resectable, pancreatic cancer

This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Record · ID 184864
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.